Daiichi Sankyo has secured a complete victory in its long-running legal dispute with NTK, as the Tokyo District Court dismissed all of the opponent's claims on September 10, 2026.
The lawsuit was initiated by Northern TK Venture Pte Ltd (NTK), a subsidiary of Malaysian firm IHH Healthcare, on October 16, 2023. The initial demand was 20 billion yen. During the proceedings, Daiichi Sankyo consistently argued that it followed proper procedures based on arbitration rulings, particularly after the Supreme Court of India halted NTK's tender offer for Fortis Healthcare.
On May 9, 2025, a petition to amend the claim was filed, expanding the demanded amount to 203.318 billion yen. The Tokyo District Court ruled that Daiichi Sankyo's actions were lawful and based on arbitration decisions, dismissing NTK's entire claim. This judicial confirmation validates the company's position, which it intends to defend even if an appeal is filed.
The judgment clarifies that there are no direct impacts on Daiichi Sankyo's corporate value or financial health.
| Item | Amount | Remarks |
|---|---|---|
| Initial Claim (2023) | 20 billion yen | NTK initial assertion |
| Expanded Claim (2025) | Approx. 203.3 billion yen | Total damages and fees |
| Judgment Result | Fully Dismissed | Complete victory for Daiichi Sankyo |
The company disclosed that the judgment has no impact on its current performance. While practical effects from litigation costs or reserves may remain, this suggests no massive financial outflow or asset reduction. Furthermore, requests to block stock acquisitions and post content on websites were rejected, removing legal constraints on management decisions. The foundation for enforcing arbitration in India is now stronger.
Daiichi Sankyo has stated it will continue to assert its legitimacy in any appeal process. While the risk of a losing verdict in international disputes has not entirely vanished, the dismissal of most claims in the first instance suggests a high likelihood of similar outcomes in subsequent trials.
End of Litigation Risk Manifestation
The resolution of this prolonged legal battle eliminates uncertainty and is expected to boost investor confidence in corporate governance. The reduction of legal barriers in the Indian market is seen as positive for mid-to-long-term growth strategies.
While attention remains on potential appeals, Daiichi Sankyo's solid financial base should lead to cautious optimism in the stock market. This case also serves as an example of corporate resilience and ethical management, demonstrating the company's ability to protect its rights effectively.
Analyst take
This judgment marks a significant milestone in Daiichi Sankyo's efforts to protect its rights in the Indian market, particularly by dismissing the massive 203.3 billion yen claim. The court's confirmation of legality adds value as a precedent for future international transactions. However, investors should note that an appeal is still possible, meaning the dispute is not fully resolved. For now, the elimination of litigation uncertainty is a positive catalyst to watch alongside growth expectations in India.
